The "Translational Research in Psychiatry" research group is based in the Department of Psychiatry and Psychotherapy at the Central Institute of Mental Health in Mannheim. Its main aim is to ensure the performance and coordination of various projects, including the CBD-ESPRIT clinical trial and the development of fluid molecular biomarkers.